Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | SQLE | Q14534 | 3/20 | 0.35 |
| ▸ | ELANE | P08246 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11223343 | 1.00 | PTPN1 (0.48) | PTPN1ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL10599229 | 0.88 | PTPN1 (0.40) | PTPN1ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL10599218 | 0.86 | PTPN1 (0.42) | PTPN1ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL16671131 | 0.83 | SQLE (0.46) | PTPN1ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL16671129 | 0.83 | SQLE (0.46) | PTPN1ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL8471068 | 0.83 | CYP1A1 (0.38) | PTPN1ALOX15ALDH1A1CYP1A1CYP1B1 | |
| SCHEMBL23779799 | 0.81 | CYP1A1 (0.37) | PTPN1ALOX15ALDH1A1CYP1A1CYP1B1 | |
| SCHEMBL21894289 | 0.81 | ALOX15 (0.43) | PTPN1ALOX15MEN1CYP3A4KMT2A | |
| SCHEMBL10600941 | 0.81 | CYP1A1 (0.37) | PTPN1ALOX15ALDH1A1CYP1A1CYP1B1 | |
| SCHEMBL10600948 | 0.81 | CYP1A1 (0.37) | PTPN1ALOX15ALDH1A1CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57024313-A | — | — | None | — | — | JP | disclosed |
| CN-111491912-B | Method for producing acrylate compound | 株式会社LG化学 | 2023-02-10 | — | — | CN | disclosed |
| EP-3686180-B1 | PROCESS FOR PRODUCING ACRYLIC ACID ESTER COMPOUND | LG CHEMICAL LTD (KR) | 2022-09-07 | — | — | EP | disclosed |
| US-11028038-B2 | Preparation method of acrylic ester compound | LG CHEM, LTD. | 2021-06-08 | — | — | US | disclosed |
| US-20200407308-A1 | Preparation Method of Acrylic Ester Compound | LG CHEM, LTD. (KR) | 2020-12-31 | — | — | US | disclosed |
| CN-111491912-A | Method for producing acrylate compound | 株式会社LG化学 | 2020-08-04 | — | — | CN | disclosed |
| EP-3686180-A1 | PROCESS FOR PRODUCING ACRYLIC ACID ESTER COMPOUND | LG Chem, Ltd. (KR) | 2020-07-29 | — | — | EP | disclosed |
| US-4338170-A | CIS-TRANS CONVERSION IN THE PRESENCE OF THIOLS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1982-07-06 | — | — | US | disclosed |
| JP-S5724313-A | CIS-TRANS ISOMERIZING METHOD OF UNSATURATED COMPOUND | NISSAN CHEM IND LTD | 1982-02-08 | — | — | JP | disclosed |
| US-4107219-A | OXIDIZING UNSATURATED AMINE, THERMAL REARRANGEMENT TO FORM UNSATURATED HYDROXYLAMINE, HYDROGENATION | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1978-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11028038-B2 | Preparation method of acrylic ester compound | NAAA, APEH, AASDHPPT | PTPN1 3909/4885ALOX15 1088/4885MEN1 920/4885 |
| US-20200407308-A1 | Preparation Method of Acrylic Ester Compound | NAAA, APEH, AASDHPPT | PTPN1 3909/4885ALOX15 1088/4885MEN1 920/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.